Bispecific antibodies in cancer immunotherapy
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Biomedical Engineering,Bioengineering,Biotechnology
Reference89 articles.
1. Bispecific antibodies: a mechanistic review of the pipeline;Labrijn;Nat Rev Drug Discov,2019
2. Bispecific antibody based therapeutics: strengths and challenges;Thakur;Blood Rev,2018
3. Next generation antibody drugs: pursuit of the’ high-hanging fruit’;Carter;Nat Rev Drug Discov,2018
4. Redirected T cell cytotoxicity in cancer therapy;Clynes;Annu Rev Med,2019
5. Bispecific T-cell engagers: towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety;Ellerman;Methods,2019
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09
2. Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors;Molecular Diagnosis & Therapy;2024-08-22
3. CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing;Communications Biology;2024-08-13
4. Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors;Cancer Immunology, Immunotherapy;2024-08-06
5. Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system;Cancer Letters;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3